Benzinga | Mar 31, 2021 06:34PM EDT

New York Times Corrects Earlier Report On Johnson & Johnson Vaccine; Says Mix-Up Only Halts 'Future Shipments' Of Vaccine And Does Not Affect Doses Currently Being Delivered Nationwide

The mixup has halted future shipments of Johnson & Johnson doses in the United States while the Food and Drug Administration investigates. Johnson & Johnson has moved to strengthen its control over Emergent BioSolutions' work to avoid further quality lapses.

The mistake is a major embarrassment for Johnson & Johnson, whose one-dose vaccine has been credited with speeding up the national immunization program.

It does not affect Johnson & Johnson doses that are currently being delivered and used nationwide. All those doses were produced in the Netherlands, where operations have been fully approved by federal regulators.